Publicação
Registo Português de Miocardiopatia Hipertrófica
| dc.contributor.author | Cardim, Nuno | |
| dc.contributor.author | Cardim, Nuno | |
| dc.contributor.author | Brito, Dulce | |
| dc.contributor.author | Rocha Lopes, Luís | |
| dc.contributor.author | Freitas, António | |
| dc.contributor.author | Araújo, Carla | |
| dc.contributor.author | Belo, Adriana | |
| dc.contributor.author | Gonçalves, Lino | |
| dc.contributor.author | Mimoso, Jorge | |
| dc.contributor.author | Olivotto, Iacopo | |
| dc.contributor.author | Elliott, Perry | |
| dc.contributor.author | Madeira, Hugo | |
| dc.contributor.institution | NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM) | |
| dc.contributor.pbl | Sociedade Portuguesa de Cardiologia | Elsevier | |
| dc.date.accessioned | 2023-01-13T22:20:47Z | |
| dc.date.available | 2023-01-13T22:20:47Z | |
| dc.date.issued | 2018-01 | |
| dc.description | Funding Information: Gold: Jaba Recordati, Merck Serono, Sanofi-Genzyme, Shire; Silver: Medinfar, Servier IOi was supported by the Italian Ministry of Health (“LVH in aortic valve disease and HCM: genetic basis, biophysical correlates and viral therapy models” (RF-2013-02356787), and NET-2011-02347173 (“Mechanisms and treatment of coronary microvascular dysfunction in patients with genetic or secondary LVH”); and by Telethon Italy (GGP13162). Publisher Copyright: © 2017 Sociedade Portuguesa de Cardiologia | |
| dc.description.abstract | Introduction: We report the results of the Portuguese Registry of Hypertrophic Cardiomyopathy, an initiative that reflects the current spectrum of cardiology centers throughout the territory of Portugal. Methods: A direct invitation to participate was sent to cardiology departments. Baseline and outcome data were collected. Results: A total of 29 centers participated and 1042 patients were recruited. Four centers recruited 49% of the patients, of whom 59% were male, and mean age at diagnosis was 53±16 years. Hypertrophic cardiomyopathy (HCM) was identified as familial in 33%. The major reason for diagnosis was symptoms (53%). HCM was obstructive in 35% of cases and genetic testing was performed in 51%. Invasive septal reduction therapy was offered to 8% (23% of obstructive patients). Most patients (84%) had an estimated five-year risk of sudden death of <6%. Thirteen percent received an implantable cardioverter-defibrillator. After a median follow-up of 3.3 years (interquartile range [P25-P75] 1.3-6.5 years), 31% were asymptomatic. All-cause mortality was 1.19%/year and cardiovascular mortality 0.65%/year. The incidence of heart failure-related death was 0.25%/year, of sudden cardiac death 0.22%/year and of stroke-related death 0.04%/year. Heart failure-related death plus heart transplantation occurred in 0.27%/year and sudden cardiac death plus equivalents occurred in 0.53%/year. Conclusions: Contemporary HCM in Portugal is characterized by relatively advanced age at diagnosis, and a high proportion of invasive treatment of obstructive forms. Long-term mortality is low; heart failure is the most common cause of death followed by sudden cardiac death. However, the burden of morbidity remains considerable, emphasizing the need for disease-specific treatments that impact the natural history of the disease. | en |
| dc.description.version | publishersversion | |
| dc.description.version | published | |
| dc.format.extent | 10 | |
| dc.format.extent | 1121815 | |
| dc.identifier.doi | 10.1016/j.repc.2017.08.005 | |
| dc.identifier.issn | 0870-2551 | |
| dc.identifier.other | PURE: 50444911 | |
| dc.identifier.other | PURE UUID: d7f96111-2853-40d0-b2bf-8ad30dc44f1c | |
| dc.identifier.other | Scopus: 85040629806 | |
| dc.identifier.other | PubMed: 29358015 | |
| dc.identifier.other | WOS: 000432448500002 | |
| dc.identifier.uri | http://hdl.handle.net/10362/147561 | |
| dc.identifier.url | https://www.scopus.com/pages/publications/85040629806 | |
| dc.language.iso | por | |
| dc.peerreviewed | yes | |
| dc.subject | Hypertrophic cardiomyopathy | |
| dc.subject | Left ventricular hypertrophy | |
| dc.subject | Outcome | |
| dc.subject | Registry | |
| dc.subject | Cardiology and Cardiovascular Medicine | |
| dc.title | Registo Português de Miocardiopatia Hipertrófica | pt |
| dc.title.alternative | The Portuguese Registry of Hypertrophic CardiomyopathyOverall results | en |
| dc.title.subtitle | resultados globais | pt |
| dc.type | journal article | |
| degois.publication.firstPage | 1 | |
| degois.publication.issue | 1 | |
| degois.publication.lastPage | 10 | |
| degois.publication.title | Revista Portuguesa de Cardiologia | |
| degois.publication.volume | 37 | |
| dspace.entity.type | Publication | |
| person.familyName | Cardim | |
| person.givenName | Nuno | |
| person.identifier.orcid | 0000-0002-3812-4872 | |
| rcaap.rights | openAccess | |
| relation.isAuthorOfPublication | bcbf3f33-253a-4b76-a55f-23e4caf28001 | |
| relation.isAuthorOfPublication.latestForDiscovery | bcbf3f33-253a-4b76-a55f-23e4caf28001 |
Ficheiros
Principais
1 - 1 de 1
A carregar...
- Nome:
- 1_s2.0_S0870255117305425_main.pdf
- Tamanho:
- 1.07 MB
- Formato:
- Adobe Portable Document Format
